HCV transmission in industrialized countries and resource-constrained areas.
about
Influence of host resistance on viral adaptation: hepatitis C virus as a case studyCapitalizing on knowledge of hepatitis C virus neutralizing epitopes for rational vaccine designHigh Prevalence and Diversity of Hepatitis Viruses in Suspected Cases of Yellow Fever in the Democratic Republic of Congo.Needle exchange programs for the prevention of hepatitis C virus infection in people who inject drugs: a systematic review with meta-analysis.Current and Future Burden of Chronic Nonmalignant Liver DiseaseProtocol for a systematic review and meta-analysis of hepatitis C virus (HCV) prevalence and incidence in the Horn of Africa sub-region of the Middle East and North AfricaTnBP⁄Triton X-45 treatment of plasma for transfusion efficiently inactivates hepatitis C virus.Association between interleukin-18 gene promoter (- 607C/A and - 137G/C) polymorphisms and chronic hepatitis C virus infections: A meta-analysis.A Multiantigenic DNA Vaccine That Induces Broad Hepatitis C Virus-Specific T-Cell Responses in MiceNew prospects for the treatment and prevention of hepatitis C in children.Structural flexibility at a major conserved antibody target on hepatitis C virus E2 antigen.Development of antiviral drugs for the treatment of hepatitis C at an accelerating pace.A cross-sectional study of hepatitis C among people living with HIV in Cambodia: Prevalence, risk factors, and potential for targeted screening.Hepatitis C virus acquisition among Egyptians: analysis of a 10-year surveillance of acute hepatitis C.Importance and Contribution of Community, Social, and Healthcare Risk Factors for Hepatitis C Infection in Pakistan.Hepatitis C Vaccines, Antibodies, and T Cells.
P2860
Q28087595-64F00CFB-E059-4FF7-ABF1-3608F2E193DDQ30374314-F8D355E4-2FAB-4192-BA9B-B121CA386C81Q33603873-CD466CF5-A054-4DAE-8339-FB52EBC6C8CEQ33702754-0E93D162-6637-4927-A6A5-2ABD5E1FECD9Q34490300-43A52CE4-4BDD-4A20-9811-F1622FAA1EBDQ34761973-70B95B09-F5BC-438E-BCD7-B48ACFE48F49Q35058574-CB67C200-1327-4638-A45C-FECA269C3501Q35645186-DAD06728-9136-4AA0-A05B-F1BAD1A705F5Q35861251-EE05F48B-CF16-4E2C-8005-2F3DFE201024Q36608054-B46BB5C5-6A4A-410B-BD11-23291D36E463Q37417839-E06199B9-24F1-414E-9CAF-1DBF673A216BQ38515906-50D004D3-F562-40AB-8F0B-D4FF418A86E7Q38967636-2BB73547-10CD-42E5-BEA6-BBED80B1067CQ39260097-492A4C82-5730-4EE0-B64A-5F55EC3B7C24Q47579352-D8CFC4FB-D8AC-4493-B198-A120EB98FC16Q55709137-CC8CE2F5-B986-4EA9-BFF0-811A3738C525
P2860
HCV transmission in industrialized countries and resource-constrained areas.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
HCV transmission in industrialized countries and resource-constrained areas.
@en
type
label
HCV transmission in industrialized countries and resource-constrained areas.
@en
prefLabel
HCV transmission in industrialized countries and resource-constrained areas.
@en
P2860
P1476
HCV transmission in industrialized countries and resource-constrained areas.
@en
P2093
Mark Thursz
P2860
P2888
P356
10.1038/NRGASTRO.2013.179
P407
P577
2013-10-01T00:00:00Z